Interleukin-2 April 12, 2017 Interleukin-2 Trade Name Teceleukin Orphan Indication Metastatic renal cell carcinoma USA Market Approval USA USA Designation Date 1990-02-05 00:00:00 Sponsor Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07110
